AMRZ Fundamental Analysis - AMRIZE LTD

Fundamental Rating

Overall AMRZ gets a fundamental rating of 2 out of 10. We evaluated AMRZ against 13 industry peers in the Construction Materials industry. Both the profitability and financial health of AMRZ have multiple concerns. AMRZ has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

AMRZ had positive earnings in the past year.

1.2 Ratios

With a Return On Assets value of 5.30%, AMRZ perfoms like the industry average, outperforming 46.15% of the companies in the same industry.

Looking at the Return On Equity, with a value of 9.88%, AMRZ is doing worse than 61.54% of the companies in the same industry.

AMRZ's Return On Invested Capital of 7.43% is in line compared to the rest of the industry. AMRZ outperforms 53.85% of its industry peers.

		Industry Rank	Sector Rank
ROA	5.3%
ROE	9.88%
ROIC	7.43%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

AMRZ has a better Profit Margin (10.89%) than 61.54% of its industry peers.

Looking at the Operating Margin, with a value of 18.16%, AMRZ is in the better half of the industry, outperforming 69.23% of the companies in the same industry.

The Gross Margin of AMRZ (26.23%) is worse than 69.23% of its industry peers.

		Industry Rank	Sector Rank
OM	18.16%
PM (TTM)	10.89%
GM	26.23%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AMRZ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

Compared to 1 year ago, AMRZ has about the same amount of shares outstanding.

AMRZ has a better debt/assets ratio than last year.

2.2 Solvency

AMRZ has an Altman-Z score of 2.50. This is not the best score and indicates that AMRZ is in the grey zone with still only limited risk for bankruptcy at the moment.

The Altman-Z score of AMRZ (2.50) is comparable to the rest of the industry.

AMRZ has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.

AMRZ has a Debt to Equity ratio of 0.45. This is comparable to the rest of the industry: AMRZ outperforms 53.85% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.45
Debt/FCF	N/A
Altman-Z	2.5

ROIC/WACC0.72

WACC10.32%

2.3 Liquidity

A Current Ratio of 1.45 indicates that AMRZ should not have too much problems paying its short term obligations.

AMRZ has a Current ratio of 1.45. This is in the lower half of the industry: AMRZ underperforms 69.23% of its industry peers.

AMRZ has a Quick Ratio of 1.45. This is a bad value and indicates that AMRZ is not financially healthy enough and could expect problems in meeting its short term obligations.

AMRZ has a worse Quick ratio (0.97) than 69.23% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.45
Quick Ratio	0.97

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.26% over the past year.

AMRZ shows a small growth in Revenue. In the last year, the Revenue has grown by 0.23%.

EPS 1Y (TTM)33.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)0.23%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 11.65% on average over the next years. This is quite good.

The Revenue is expected to grow by 5.08% on average over the next years.

EPS Next Y3.59%

EPS Next 2Y8.96%

EPS Next 3Y11.02%

EPS Next 5Y11.65%

Revenue Next Year3.3%

Revenue Next 2Y3.78%

Revenue Next 3Y4.43%

Revenue Next 5Y5.08%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.51 indicates a rather expensive valuation of AMRZ.

AMRZ's Price/Earnings ratio is a bit cheaper when compared to the industry. AMRZ is cheaper than 61.54% of the companies in the same industry.

When comparing the Price/Earnings ratio of AMRZ to the average of the S&P500 Index (26.51), we can say AMRZ is valued inline with the index average.

The Price/Forward Earnings ratio is 19.76, which indicates a rather expensive current valuation of AMRZ.

AMRZ's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AMRZ is cheaper than 69.23% of the companies in the same industry.

AMRZ is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.13, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	23.51
Fwd PE	19.76

4.2 Price Multiples

AMRZ's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AMRZ is cheaper than 61.54% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	11.54

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

PEG (NY)6.54

PEG (5Y)N/A

EPS Next 2Y8.96%

EPS Next 3Y11.02%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

AMRZ does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

AMRIZE LTD

NYSE:AMRZ (12/31/2025, 8:04:00 PM)

After market: 54.08 0 (0%)

54.08

-0.88 (-1.6%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryConstruction Materials

Earnings (Last)10-28 2025-10-28/amc

Earnings (Next)N/A N/A

Inst Owners37.75%

Inst Owner ChangeN/A

Ins Owners7.13%

Ins Owner Change49.27%

Market Cap29.91B

Revenue(TTM)11.70B

Net Income(TTM)1.27B

Analysts77.5

Price TargetN/A

Short Float %1.59%

Short Ratio1.82

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-14.79%

Min EPS beat(2)-33.5%

Max EPS beat(2)3.92%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-5.16%

Min Revenue beat(2)-8.34%

Max Revenue beat(2)-1.97%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)0%

EPS NQ rev (3m)N/A

EPS NY rev (1m)-2.1%

EPS NY rev (3m)-7.31%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0.31%

Revenue NY rev (3m)0.17%

Valuation

		Industry Rank	Sector Rank
PE	23.51
Fwd PE	19.76
P/S	2.56
P/FCF	N/A
P/OCF	N/A
P/B	2.32
P/tB	13.94
EV/EBITDA	11.54

EPS(TTM)2.3

EY4.25%

EPS(NY)2.74

Fwd EY5.06%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS21.16

BVpS23.33

TBVpS3.88

PEG (NY)6.54

PEG (5Y)N/A

Graham Number34.74

Profitability

		Industry Rank	Sector Rank
ROA	5.3%
ROE	9.88%
ROCE	10.18%
ROIC	7.43%
ROICexc	7.72%
ROICexgc	16.16%
OM	18.16%
PM (TTM)	10.89%
GM	26.23%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-ScoreN/A

Asset Turnover0.49

Health

		Industry Rank	Sector Rank
Debt/Equity	0.45
Debt/FCF	N/A
Debt/EBITDA	1.93
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.45
Quick Ratio	0.97
Altman-Z	2.5

F-ScoreN/A

WACC10.32%

ROIC/WACC0.72

Cap/Depr(3y)69.39%

Cap/Depr(5y)N/A

Cap/Sales(3y)5.14%

Cap/Sales(5y)N/A

Profit Quality(3y)137.06%

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)33.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next Y3.59%

EPS Next 2Y8.96%

EPS Next 3Y11.02%

EPS Next 5Y11.65%

Revenue 1Y (TTM)0.23%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next Year3.3%

Revenue Next 2Y3.78%

Revenue Next 3Y4.43%

Revenue Next 5Y5.08%

EBIT growth 1Y13.63%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year45.34%

EBIT Next 3Y18.7%

EBIT Next 5Y14.65%

FCF growth 1Y16.64%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y12.08%

OCF growth 3YN/A

OCF growth 5YN/A

AMRIZE LTD / AMRZ FAQ

Can you provide the ChartMill fundamental rating for AMRIZE LTD?

ChartMill assigns a fundamental rating of 2 / 10 to AMRZ.

What is the valuation status of AMRIZE LTD (AMRZ) stock?

ChartMill assigns a valuation rating of 2 / 10 to AMRIZE LTD (AMRZ). This can be considered as Overvalued.

What is the profitability of AMRZ stock?

AMRIZE LTD (AMRZ) has a profitability rating of 2 / 10.

What is the financial health of AMRIZE LTD (AMRZ) stock?

The financial health rating of AMRIZE LTD (AMRZ) is 3 / 10.

AMRIZE LTD (AMRZ) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

AMRIZE LTD / AMRZ FAQ

Can you provide the ChartMill fundamental rating for AMRIZE LTD?

What is the valuation status of AMRIZE LTD (AMRZ) stock?

What is the profitability of AMRZ stock?

What is the financial health of AMRIZE LTD (AMRZ) stock?